Drug Trial Radar · NCT03307980
Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia B
Last checked: Nov 20, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
21
Actual
Start
Jun 22, 2017
Primary completion
Jul 23, 2026
Study completion Jul 23, 2026
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Oct 12, 2017
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Long-term safety and efficacy follow-up for participants with Hemophilia B who were previously treated in the C0371005 (formerly SPK-9001-101) study, and a dose-escalation sub-study evaluating safety, tolerability, and kinetics of a higher dose with long-term safety and efficacy follow-up. Participants in the substudy do not need to have participated in C0371005.
Conditions
- Hemophilia B
Interventions
PF-06838435 (formerly SPK-9001)Biological
Gene Therapy: A novel, bioengineered adeno-associated viral vector carrying human factor IX variant
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of PF-06838435 related adverse eventsTime frame: Baseline up to Year 6
Locations
25 sites in 4 countries. Site status is shown where the registry gives one.
UC Davis Comprehensive Cancer Center
Sacramento, California
UC Davis Ellison Ambulatory Care Clinic
Sacramento, California
UC Davis Medical Center department of Radiology
Sacramento, California
UC Davis Medical Center
Sacramento, California
UC Davis Midtown Cancer Center
Sacramento, California
UC DavisHealth Main Hospital
Sacramento, California
LA Center for Bleeding and Clotting Disorders - Metairie
Metairie, Louisiana
Tulane Lakeside Hospital
Metairie, Louisiana
LA Center for Bleeding and Clotting Disorders
New Orleans, Louisiana
Tulane University Clinical Translational Unit
New Orleans, Louisiana
Tulane University Hospitals and Clinic
New Orleans, Louisiana
Tulane University School of Medicine
New Orleans, Louisiana
University Medical Center New Orleans
New Orleans, Louisiana
Louisiana Center for Advanced Medicine
Slidell, Louisiana
Mississippi Center for Advanced Medicine
Madison, Mississippi
Weill Cornell Medicine - New York Presbyterian Hospital
New York, New York
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia
McMaster University Medical Centre - Hamilton Health Sciences
Hamilton, Ontario, Canada
McMaster University
Hamilton, Ontario, Canada
The Research Institute of the McGill University Health Centre
Montreal, Quebec, Canada
McGill University Health Center - Research Institute
Montreal, Quebec, Canada
Istanbul Universitesi Onkoloji Enstitusu Çocuk Hematoloji Onkoloji Bilim Dali
Istanbul, Turkey (Türkiye)
Istanbul University Clinical Trials Excellence Center
Istanbul, Turkey (Türkiye)
Ege Universitesi Tip Fakultesi Cocuk Sagligi ve Hastaliklari Anabilim Dali
Izmir, Turkey (Türkiye)
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.